Pharmablock Yaoshi convertible bonds face mandatory redemption

Nanjing Pharmablock Sciences Co., Ltd. announced that its Yaoshi convertible bonds (stock code: 123145) will cease trading on September 15, 2025, and stop allowing share conversions on September 18, 2025. The final day for bondholders to convert their bonds into shares is September 17, 2025. Unconverted bonds will be forcibly redeemed at a price of 100.62 yuan per bond, which includes the par value and accrued interest. This redemption price is based on the current annual interest rate of 1.5%.

The company warns that the market price of the convertible bonds prior to the cessation of trading and conversion may differ significantly from the redemption price. Bondholders who do not convert their bonds by the deadline may incur investment losses. Investors are reminded that to convert bonds, they must have a valid ChiNext trading account. The redemption date for the convertible bonds is September 18, 2025, with funds expected to be disbursed to investors by September 25, 2025.